The plaintiff-appellant, Deprenyl Animal Health, Inc. (“DAHI”), seeks review of the final judgment of the United States District Court for the District of Kansas dismissing the case in its entirety. The district court held that the exercise of jurisdiction over the defendant-appellee, the University of Toronto Innovations Foundation (“UTIF”), would violate due process. Consequently, the district court granted UTIF’s motion to dismiss for lack of personal jurisdiction or, in the alternative, to dismiss pending binding arbitration. For .the reasons explained below, we hold that the exercise of personal jurisdiction over UTIF is consistent with the requirements of due process. We therefore reverse the dismissal and remand with instructions to stay proceedings in the district court pending the outcome of the arbitration proceedings.
I. BACKGROUND
The plaintiff, DAHI, is a corporation organized under Louisiana law that maintains its principal place of business in Overland Park, Kansas. DAHI is a subsidiary of a Canadian corporation, Draxis Health Inc. (“Draxis”), which is headquartered in Ontario.
The defendant, UTIF, is a corporation organized under Canadian law that maintains its offices in Toronto, Canada. UTIF is a technical licensing company that assists the University of Toronto with commercialization of the inventions developed by its academics. UTIF neither owns nor operates any Kansas facilities. It employs no one in Kansas and has neither sold nor advertised any products there.
In 1991, DAHI approached UTIF seeking a license under certain of UTIF’s patent applications. In 1992, DAHI and UTIF entered into a license agreement for technology that matured into UTIF’s United States Patent No. 5,767,164 (“the '164 patent”). UTIF’s president negotiated the essential terms of the license agreement with the president of Draxis (then known as Deprenyl Research Limited), in Toronto. Athough Draxis is now DAHI’s parent, at the time of the negotiations, Draxis was only a minority shareholder. Nevertheless, the president of Draxis negotiated on behalf of DAHI. DAHI alleges that Draxis itself had no involvement in the negotiations.
After the parties signed a letter of intent, DAHI and UTIF entered into a
*1347
course of dealings during which UTIF’s president regularly made telephone and mail contact with DAHI’s president in Kansas. DAHI alleges that UTIF’s president traveled to Kansas once in 1991 to negotiate the license agreement and again in 1994 to resolve a dispute that resulted in an amendment to the agreement. UTIF asserts that its president does not recall the 1991 visit. The district court, however, did not hold an evidentiary hearing regarding jurisdiction. Therefore the court properly noted that all factual disputes must be resolved in DAHI’s favor in order to evaluate its prima facie showing of jurisdiction.
Deprenyl Animal Health, Inc. v. Univ. of Toronto Innovations Found.,
Federal Circuit law governs the resolution of this jurisdictional dispute, but it accords with Tenth Circuit law on this issue.
See Graphic Controls Corp. v. Utah Med. Prods., Inc.,
The parties entered into the license agreement on May 21 and 22, 1992, by signing separate copies of the agreement in Toronto, and Overland Park, respectively. As the agreement required, UTIF kept DAHI informed of the status of prosecution of the application that matured into the '164 patent. This included sending copies of patent applications and PTO correspondence to DAHI in Kansas. DAHI paid licensing fees to UTIF from Kansas, but in Canadian dollars.
The license' agreement contains two clauses that are implicated by the present appeal: an arbitration clause and a choice of law clause. The arbitration clause provides:
16. ARBITRATION
16.1 In the event that any disagreement shall, from time to time, arise between the parties in connection with the interpretation, application or effect of this Agreement, then such disagreement shall be settled and determined by arbitration in accordance with the procedure agreed to by the parties within a period of fifteen (15) days following notice of such dispute to both parties and filing such agreement, in accordance with the provisions of the Arbitrations Act (Ontario).
The choice of law clause provides:
19. GOVERNING LAWS
19.1 This Agreement shall be interpreted and construed, and the legal relation contained therein shall be determined, in accordance with the laws of the Province of Ontario, Canada.
The present dispute began in December 1998, when DAHI’s parent, the Canadian corporation, Draxis, issued a press release announcing FDA approval of a drug called Anipryl, which is used to treat canine cognitive dysfunction. In February 1999, UTIF sent a notice to DAHI contending that sales of Anipryl would be subject to the royalty provisions of the license agreement. UTIF sent the notice letter to DAHI at the Kansas address stated in the license agreement. DAHI’s president responded in a letter-written with Ontario *1348 letterhead. All subsequent communications between UTIF and DAHI were sent to the parties’ Canadian offices.
On May 25, 2000, DAHI filed the complaint in the present action in the district of Kansas, seeking a declaratory judgment that the license agreement is inapplicable to the sale of Anipryl and that the '164 patent is invalid and not infringed by the sale of Anipryl. On July 26, 2000, UTIF initiated arbitration in Canada. On July 28, 2000, DAHI filed an application in Canadian Superior Court, seeking a declaration that the dispute is incapable of being the subject of arbitration in Ontario. The district court took note
that on July 28, 2000, plaintiff filed a lawsuit against defendant in the Superior Court of Justice in Ontario, Canada, seeking inter alia a declaration that the license agreement does not apply to plaintiff, that plaintiffs product is not covered by the agreement, and that plaintiffs product is not covered by the licensed patent.
DAHI at 1278. On March 4, 2002, the Ontario Superior Court of Justice ordered the Canadian court and arbitration proceedings stayed pending the determination of the present appeal before this court.
UTIF filed a motion to dismiss the district court case for lack of personal jurisdiction or, in the alternative, to dismiss pending binding arbitration. The district court granted UTIF’s motion in its entirety without reaching the arbitration issue. See generally DAHI; see also Deprenyl Animal Health, Inc. v. Univ. of Toronto Inoovations [sic.] Found., No. 00-2234 CM, (D.Kan. Aug.20, 2001) (entry of judgment dismissing case in its entirety). The court held that it lacked personal jurisdiction over UTIF. DAHI at 1278-79. After noting that the Kansas long arm statute authorizes the exercise of jurisdiction to the full extent permitted by the constitution, the district court analyzed whether the exercise of jurisdiction over UTIF would comport with due process. Id. at 1275. According to the district court, it would not. Although UTIF had sufficient minimum contacts with Kansas, the exercise of jurisdiction would nevertheless violate due process; it would be so unreasonable as to violate fair play and substantial justice. Id. at 1278.
DAHI appeals. This court has jurisdiction pursuant to 28 U.S.C. § 1295(a)(1) because the district court’s jurisdiction was based, in part, on 28 U.S.C. § 1338.
II. STANDARD OF REVIEW
Federal Circuit law governs the issue of personal jurisdiction in this patent-related case.
See Hildebrand v. Steck Mfg. Co., Inc.,
In contrast, regional circuit law governs the determination of whether DAHI’s claims for noninfringement and invalidity fall within the scope of the arbitration clause of the parties’ agreement. This is so because we apply Federal Circuit law only “to both substantive and procedural issues ‘intimately involved in the substance of enforcement of the patent right.’ ”
Flex-Foot, Inc. v. CRP, Inc.,
III. DISCUSSION
On appeal, DAHI contends that the district court erred by determining that the exercise of personal jurisdiction over UTIF would violate due process. DAHI further contends that litigation on the invalidity and noninfringement issues should proceed despite the initiation of arbitration proceedings in Canada because those issues fall outside the scope of the arbitration clause. UTIF contends that this court should affirm the district court’s dismissal both because the exercise of jurisdiction over UTIF would violate due process and because the agreement requires the infringement and validity issues to be resolved by binding arbitration in Canada. For the reasons explained below, we conclude that the exercise of personal jurisdiction over UTIF comports with the requirements of due process. We therefore reverse the dismissal and remand with instructions to stay proceedings pending the outcome of the Canadian arbitration proceedings.
A. Personal Jurisdiction
As the district court noted, before a federal court can exercise personal jurisdiction over a defendant in a federal question case, the court must determine whether an applicable statute potentially confers jurisdiction by authorizing service of process on the defendant, and whether the exercise of jurisdiction would satisfy the requirements of due process. Hilde
*1350
brand,
The Kansas long-arm statute authorizes the exercise of jurisdiction to the full extent permitted by the constitution.
Matter of Hesston Corp.,
Because this is a federal question case, the due process requirements of the Fifth Amendment are at issue.
See Beverly Hills Fan Co. v. Royal Sovereign Corp.,
International Shoe
and its progeny establish a two-pronged test for whether the exercise of jurisdiction comports with due process. First, the defendant must have “minimum contacts” with the forum. Where a defendant’s contacts are continuous and systematic, due process permits the exercise of general jurisdiction.
See LSI Indus. Inc. v. Hubbell Lighting, Inc.,
In
Akro,
this court described the pertinent Supreme Court jurisprudence by articulating a three-factor test.
In the instant case, the district court determined that UTIF had sufficient minimum contacts with Kansas. Nevertheless, it held that the exercise of jurisdiction over UTIF would be so unreasonable as to violate due process. We agree with the district court that UTIF’s contacts with Kansas are sufficient. We disagree that subjecting UTIF to the present litigation in Kansas would be so unreasonable as to violate fair play and substantial justice. Consequently, we conclude that the exercise of jurisdiction over UTIF by the district court in this case comports with due process.
1. Minimum Contacts
The district court concluded, correctly, that UTIF had sufficient minimum contacts with Kansas.
DAH.I
at 1277. In fact, UTIF’s contacts with the forum state surpassed those of the defendants in
Inamed,
In
Inamed
this court reversed a dismissal for lack of personal jurisdiction by a California district court over a declaratory judgment defendant-patentee who, was a resident of New Jersey.
Similarly, this court reversed a dismissal for lack of personal jurisdiction over the declaratory judgment defendant-patentee in
Akro
notwithstanding the fact that neither he nor his agent had been to the forum state".
UTIF’s contacts with Kansas are at least as significant. UTIF purposefully directed activities at DAHI, in Kansas. Although DAHI initially contacted UTIF about the prospect of licensing certain of UTIF’s technology, UTIF responded with telephone calls and letters to negotiate the agreement. Moreover, UTIF’s president twice traveled to Kansas to negotiate, and amend, the resulting ongoing license agreement pertaining to the technology that developed into the '164 patent. As the license agreement required, UTIF sent DAHI, in Kansas, copies of correspondence with the patent office and kept DAHI apprised of the prosecution status of the application that matured into the '164 patent. UTIF also sent a letter contending that Anipryl is subject to the license agreement to DAHI in Kansas. These constitute sufficient minimum contacts.
DAHI’s declaratory judgment suit, which seeks a declaration that Anipryl is not covered by the license agreement and that the '164 patent is invalid and not infringed by Anipryl, directly relates to UTIF’s contacts with DAHI in Kansas.
See Inamed,
UTIF attempts to escape this result by pointing out that other courts have declined to exercise jurisdiction where the defendant’s contact with the forum consisted primarily of negotiating an agreement that contained forum selection or choice of law provisions selecting a foreign state or country. In support of this contention, UTIF cites five decisions, in which our sister circuits have deemed the exercise of jurisdiction unconstitutional due, at least in part, to foreign forum selection or choice of law clauses in the contracts at issue.
See LiButti v. United States,
These cases are inapposite. None of these eases involved agreements to license technology protected by a United States Patent. Obtaining such a patent is a meaningful contact with the United States; it requires a patentee purposefully to avail him or herself of a significant benefit of United States law.
Nat'l Patent Dev. Corp. v. T.J. Smith & Nephew Ltd.,
Licensing the practice of the invention claimed in a United States patent constitutes additional purposeful availment of the benefits of United States patent law.
See Genetic Implant Sys.,
We are not persuaded that the inclusion of foreign choice of forum and choice of law provisions in a license agreement for a United States patent diminishes the significance of UTIF’s contacts with Kansas or of its purposeful availment of the benefits of licensing the '164 patent. As a contractual matter, these clauses may control. But as a constitutional matter the arbitration and Canadian choice of law clauses fail to undermine the sufficiency of UTIF’s contact with Kansas. By obtaining the '164 patent and licensing it to DAHI in Kansas, UTIF purposefully availed itself of significant benefits of United States law. The '164 patent affords UTIF the right to exclude others from making, using, selling, or offering the claimed invention for sale in the United States. See id. As we have explained, when UTIF negotiated with DAHI in Kansas for an ongoing license to practice the claimed invention, UTIF engaged in even greater contact with the forum than this court found sufficient in Inamed and Akro. The arbitration and Canadian choice of law provisions cannot render those contacts insufficient because by licensing the '164 patent UTIF contracted for and received consideration in exchange for surrendering the right to exclude, a property right uniquely granted to UTIF by United States patent law. UTIF’s purposeful availment was substantial; UTIF exercised the privileges of conducting business in Kansas and exploiting the benefits of its United States patent by licensing the patent to a Kansas operation. This remains so regardless of the forum and law that are to determine the terms of the parties’ contractual exchange of patent rights, and regardless of the fact that DAHI’s parent is a Canadian corporation.
The Supreme Court’s decision in
Burger .King
is consistent with this result. In
Burger King,
the Supreme Court stated that choice of law provisions alone would be insufficient to confer personal jurisdiction in the chosen forum.
We therefore conclude that UTIF’s contacts with Kansas satisfy due process. Unless UTIF can demonstrate that other considerations would render the exercise of jurisdiction so unreasonable as to violate *1355 fair play and substantial justice, we must reverse the dismissal for lack of personal jurisdiction.
2. Fair Play and Substantial Justice
Although the district court found that UTIF had sufficient minimum contacts with Kansas, it nevertheless dismissed for lack of personal jurisdiction because it determined that the exercise of jurisdiction would be constitutionally unreasonable. We disagree.
Determining whether UTIF has demonstrated that the exercise of jurisdiction would be so unreasonable as to violate fair play and substantial justice requires consideration of several factors.
Inamed,
UTIF argues that these factors render the exercise of jurisdiction constitutionally unreasonable. First, it notes that other courts apply a sliding scale in assessing reasonableness, requiring the defendant to make less of a showing to establish unreasonableness when the showing of minimum contacts is weak.
See, e.g., Ticketmaster-New York, Inc. v. Alioto,
We disagree with UTIF on each of the pertinent factors. Initially, we leave for another day the question whether to adopt the First Circuit’s sliding scale approach to the reasonableness inquiry; there is no need to consider whether UTIF may establish unreasonableness with a less stringent showing because we do not find the showing of minimum contacts weak. Rather, as we have explained at length, obtaining a United States patent and negotiating an ongoing license of the claimed invention constitute .substantial contacts with DAHI in Kansas. This litigation arises out of those contacts. Through those contacts UTIF purposefully availed itself of the privileges of conducting business in Kansas, and of exploiting the benefits of the '164 patent. These are not the kind of tenuous contacts that would enable UTIF to invoke the sliding scale in order to demonstrate unreasonableness with a less stringent showing than would otherwise be required.
Cf. Ticketmaster-New York,
In any event, the factors pertinent to our reasonableness inquiry fail to demonstrate that subjecting UTIF to litigation in Kansas would violate fair play and substantial justice. First, although it is true that UTIF’s status as a Canadian corporation is not insignificant, the burden of subjecting UTIF to litigation in Kansas is relatively minimal.
Cf. Aristech Chem. Int’l, Ltd. v. Acrylic Fabricators,
Second, Kansas has a substantial interest in the resolution of the patent-related dispute between DAHI and UTIF. In
Beverly Hills Fan Co.,
Third, DAHI’s interest in resolving the dispute in Kansas, the forum it selected, is compromised by the Canadian arbitration clause. The clause does not, however, undermine the constitutional reasonableness of requiring UTIF to litigate in Kansas.
Fourth, the efficient resolution of disputes is not necessarily fostered by resolution of the dispute in either forum. The choice of law clause provides that Canadian law applies to interpretation of the agreement, but even if the parties agreed to arbitrate the validity of the '164 patent, we have no reason to assume a Canadian court or arbitration panel would apply anything other than United States law to that issue. It is therefore likely that adjudicating the entire dispute in either forum would require the application of foreign law to some issues. Moreover, because parties are not required to arbitrate that which falls outside the scope of their arbitration agreement, either forum might decline to decide the entire dispute. Consequently, the efficiency factor fails to demonstrate the unreasonableness of subjecting UTIF to litigation of this dispute in Kansas.
Finally, the shared interest of the several states in furthering fundamental substantive social policies does not render the exercise of jurisdiction unreasonable. The policy of promoting uniform interpretation and enforcement of United States patent law may weigh in favor of Kansas, and the policy' of promoting the enforcement of arbitration agreements may weigh in favor of Canada. This tension prevents either policy consideration from being dispositive of the constitutional issue.
Consequently, considering all pertinent factors, this is not one, of those “rare cases” in which the defendant has demonstrated a compelling case of unreasonableness.
Beverly Hills Fan Co.,
B. Arbitration
UTIF contends that, in the alternative, this court should affirm the dismissal on the grounds that the arbitration clause of the agreement requires all issues including whether Anipryl infringes the '164 patent and whether the patent is invalid to be resolved by binding Canadian arbitration. DAHI counters that the arbitration clause is not so broad as to encompass the infringement and invalidity claims. Because it is the province of the Canadian courts to determine the scope of the arbitration provision in the first instance, we remand to the district court with instructions to stay proceedings pending the outcome of the Canadian arbitration proceedings.
Nothing prevents patent-related disputes such as this one from being resolved in binding foreign arbitration. As with other property rights, patent-related rights can be contracted away.
See Flex-Foot, Inc.,
Moreover, the Supreme Court has recognized a strong federal policy in favor of arbitration, particularly in the international realm.
Mitsubishi Motors Corp. v. Soler Chrysler Plymouth, Inc.,
DAHI contends that, notwithstanding the arbitration clause in its agreement, it should not be bound to arbitrate. This is so, it maintains, because the Canadian arbitration proceedings may apply Canadian law to the issue of the validity of the '164 patent, and Canadian law may estop DAHI, as a licensee, from challenging the patent’s validity. In
Mitsubishi Motors,
the Supreme Court rejected a similar argument.
Id.
at 636,
To be sure, the international arbitral tribunal owes no prior allegiance to the *1358 legal norms of particular states; hence, it has no direct obligation to vindicate their statutory dictates. The tribunal, however, is bound to effectuate the intentions of the parties. Where the parties have agreed that the arbitral body is to decide a defined set of claims which includes, as in these cases, those arising from the application of American antitrust law, the tribunal therefore should be bound to decide that dispute in accord with the national law giving rise to the claim.
Id.
at 636-37,
Likewise, we see no reason to presume that the Canadian arbitral, panel will apply Canadian law to determine the validity of the United States patent. In fact, it is uncertain whether the issue of validity necessarily falls within the scope of what the parties agreed to arbitrate. That is an issue for the Canadian courts to determine, at least in the first instance.
Because the agreement contains a broad arbitration clause, and because the present dispute including DAHI’s allegations of noninfringement and invalidity arose from UTIF’s July 28, 2000 letter contending that the sale of Anipryl is subject to the license agreement, considerations of international comity demand that the district court stay proceedings in the present litigation pending the outcome of the Canadian arbitration. Should the Canadian court determine that either the noninfringement or invalidity issues fall outside the scope of the arbitration clause, the district court may address them at that time. We express no view as to whether the decision of the Canadian court regarding arbitrability will be binding in the district court proceedings.
IV. CONCLUSION
Because the exercise of personal jurisdiction over UTIF is consistent with'the requirements of due process, we reverse the dismissal of DAHI’s complaint, and remand to the district court. On remand, the district court should stay proceedings in this case pending the outcome of the Canadian arbitration. The district court’s decision is
REVERSED and REMANDED.
No costs.
